The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice
Authors:
- 3 February 2022
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 28 (7) , 983-989
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (APP1140617)
This publication has 28 references indexed in Scilit:
- Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa BiofilmsPLOS ONE, 2017
- Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosaToxins, 2016
- RecurrentPseudomonas aeruginosaInfection in Chronic Lung Diseases: Relapse or Reinfection?Tuberculosis and Respiratory Diseases, 2014
- Evaluation of lytic activity of staphylococcal bacteriophage Sb‐1 against freshly isolated clinical pathogensMicrobial Biotechnology, 2011
- The effect ofPseudomonas aeruginosaon pulmonary function in patients with bronchiectasisEuropean Respiratory Journal, 2006
- Lung Infections Associated with Cystic FibrosisClinical Microbiology Reviews, 2002
- Pulmonary Inflammation Induced byPseudomonas aeruginosaLipopolysaccharide, Phospholipase C, and Exotoxin A: Role of Interferon Regulatory Factor 1Infection and Immunity, 2002
- Cytokines IL-1 β, IL-6, and TNF- α Enhance In Vitro Growth of BacteriaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Cytokines in sputum and serum from patients with cystic fibrosis and chronic pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs.Pediatric Pulmonology, 1993
- A function of Pseudomonas aeruginosa PAO polar pili: twitching motilityCanadian Journal of Microbiology, 1980